Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease proteinuria
Phenotype C0017661|iga nephropathy
Sentences 23
PubMedID- 23741418 Emerging clinical and animal studies have demonstrated that vitamin d and its analog reduce proteinuria in patients with iga nephropathy [2], non-dialysed chronic kidney disease stage 4–5 [3], [4], diabetic nephropathy [5], and animal models such as subtotally nephrectomized model [6], diabetic nephropathy model [7], adriamycin-induced nephropathy [8], puromycin-induced nephropathy [9], [10].
PubMedID- 20594038 The authors measured the extent of foot process effacement in 100 iga nephropathy cases with proteinuria and correlated it with the amount of proteinuria.
PubMedID- 23713873 Calcitriol (0.5 microg calcitriol twice per week) has been effective in decreasing proteinuria in patients with iga nephropathy.
PubMedID- 24721885 Conclusions: the findings in this cohort and previous studies suggest that rare cases of mild iga nephropathy with nephrotic range proteinuria exhibit a clinical presentation, biopsy findings, treatment response, and outcome more typical of iga nephropathy with superimposed minimal change disease.
PubMedID- 23331443 Conclusion: for early iga nephropathy patients with minimal proteinuria, normal blood pressure, and normal renal function, treatment with 2.5 mg/daily of ramipril for 5 years does not offer any benefit.
PubMedID- 24707402 Before the eradication therapy the mean proteinuria of patients with mn, iga nephropathy and fsgs were 2.42 +/- 3.24 g/day, 2.12 +/- 1.63 g/day and 1.80 +/- 1.32 g/day, respectively.
PubMedID- 22456060 Some iga nephropathy (igan) patients with massive proteinuria showed resistance to steroids and/or cytotoxic immunosuppressants based on the supportive therapy with renin- angiotensin system blockade.
PubMedID- 23557791 Aims: both steroid pulse (sp) monotherapy and the combination of tonsillectomy and sp therapy (tsp) are effective for achieving clinical remission (cr), defined as negative hematuria and proteinuria, in patients with iga nephropathy (igan).
PubMedID- 20826744 Conclusions: among patients with primary glomerulopathy and nephrotic-range proteinuria, normoalbuminaemia is associated with iga nephropathy.
PubMedID- 23977072 In another report, among 121 iga nephropathy patients with proteinuria ≥1 g/day at presentation or during follow-up period, reduced proteinuria group (in which proteinruia was decreased to <1 g/day at last follow-up) showed better outcome compared to persistent proteinuria group and showed similar renal outcome as in low proteinuria group [7].
PubMedID- 23326865 In two small studies, the addition of aliskiren to arb was shown to decrease proteinuria in subjects with iga nephropathy and various forms of primary glomerulonephritis [13, 14].
PubMedID- 22086123 Reported on the natural history of mild or early-stage iga nephropathy in patients with proteinuria <0.4 g/day over an observation period of 7 years [5].
PubMedID- 21533280 Recently, cheng's review [46] illustrated that glucocoticoids significantly induced a protection of renal function and a reduction of proteinuria in patients with iga nephropathy.
PubMedID- 23197956 Successful treatment of adult iga nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine.
PubMedID- 22019331 Conclusions: the addition of calcitriol to a renin-angiotensin system inhibitor resulted in a safe decrease in proteinuria in patients with iga nephropathy.
PubMedID- 23675422 The primary objective of the present study is to evaluate the safety and short-term efficacy of aliskiren, a direct renin inhibitor, on proteinuria reduction in patients with iga nephropathy.
PubMedID- 23049672 Oral calcitriol treatment reduced proteinuria in patients with iga nephropathy [172].
PubMedID- 20843592 Conclusions: thujone-free wormwood with its favorable safety profile can be an alternative supplement to manage proteinuria in patients with iga nephropathy.
PubMedID- 26289088 Background: sometimes, acute and progressive proteinuria increases occur in patients with iga nephropathy (igan) after favorable long-term clinical courses of >10 years, but their clinical and histological characteristics are not well understood.
PubMedID- 21655166 [2122] the ii genotype has been reported to be associated with more favorable prognosis and decreased proteinuria in patients with iga nephropathy.
PubMedID- 23502465 Reported a down-regulation of nestin expression in fsgs, mn and iga nephropathy with proteinuria, and the glomerular nestin expression levels correlated inversely with the 24-hour urine protein results [11].
PubMedID- 26239462 Urinary ngal levels also correlated with the degree of proteinuria in patients with iga nephropathy [16] and membranous nephropathy [14,15].
PubMedID- 26527894 Most of the study population included diabetic nephropathy, lupus nephropathy, and iga nephropathy with persistent proteinuria, and received corticosteroid therapy, confirming the need for validating gfr equations in this setting.

Page: 1